Skip to main navigation menu Skip to main content Skip to site footer

Artigo Original

Vol. 3 No. 2 (2022)

Effectiveness of bariatric surgery in Diabetes Mellitus type 02

DOI
https://doi.org/10.54257/2965-0585.v3.i2.55
Submitted
May 26, 2023
Published
2023-07-06

Abstract

Obesity, especially morbid obesity - BMI greater than or equal to 40 kg/m² - has been identified as one of the main risk factors for the development of Type 2 Diabetes Mellitus (DM2). One of the treatment options for obesity and for DM2 is bariatric surgery. This is a cross-sectional, analytical and retrospective study based on medical records of patients undergoing bariatric surgery in a secondary hospital in Fortaleza, Ceará, from November 2018 to February 2021, evaluating the pre- and postoperative glycemic profile. In our study, after the inclusion and exclusion criteria, 18 patients were selected. All patients had significant postoperative weight loss during the evaluation period, with improved BMI, usually with a change in classification. Only one patient did not change the BMI classification, remaining morbidly obese and with low weight loss. In general, at the time before the surgical therapy, fifteen individuals were using some hypoglycemic therapy, of these, two were using insulin and oral hypoglycemic agents. In the follow-up, sixteen patients did not use any medication for glycemic control and 02 continued to use oral hypoglycemic agents, of which one patient was insulin dependent. A highly significant difference was observed between the use of pre- and postoperative medications, with p < 0.001.

References

  1. WHO - WORLD HEALTH ORGANIZATION. Body mass index classification - report of a WHO consultation on obesity. Geneva: WHO, 1995.
  2. Nóbrega AGS et al. Cirurgia Bariátrica e Deficiências Nutricionais: Prevenir e Tratar. Revista Científica Hospital e Maternidade José Martiniano de Alencar, v. 1, n. 1, p. 28-34, 2019.
  3. Ribas F, Durval et al. Avaliação de níveis lipêmicos e glicêmicos pré e pós cirurgia bariátrica. Revista Brasileira de Clinica Medica, v. 7, p. 205-210, 2009.
  4. Brasil. Ministério da Saúde. Vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico (VIGITEL): estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no distrito federal em 2018. Brasília: Ministério da Saúde, 2018.
  5. Finkelstein E A. et al. Obesity and severe obesity forecasts through 2030. American Journal of Preventive Medicine, v. 42, n. 6, p. 563-570, 2012.
  6. Carvalho PS et al. Cirurgia bariátrica cura síndrome metabólica? Arquivos Brasileiros de Endocrinologia & Metabologia, v. 51, p. 79-85, 2007.
  7. Freitas APD et al. Perfil glicêmico e lipídico de pacientes submetidos a cirurgia bariátrica.RBONE-Revista Brasileira de Obesidade, Nutrição e Emagrecimento, v. 14, n. 87, p. 671-679, 2020.
  8. Duncan B B. et al. Medicina Ambulatorial: condutas de atenção primária baseadas em evidências. 3. ed. Porto Alegre: Artmed, 2013.
  9. Brasil. Ministério da Saúde. Protocolos de encaminhamento da atenção básica para a atenção especializada: endocrinologia e nefrologia. Brasília: Ministério da Saúde, 2016.
  10. Lemos M C M, Qualidade de vida de pacientes submetidos a cirurgia bariátrica no município de Cascavel/PR. Arquivos de Ciências da Saúde da UNIPAR, v. 10, n. 3, 2006.
  11. Lee, W-J et al. Effects of obesity surgery on the metabolic syndrome. Archives of Surgery, v. 139, n. 10, p. 1088-1092, 2004.
  12. AACE, T. A. Bariatric surgery guidelines. Surgery for Obesity and Related Diseases, v. 5, n. 4, p. 109-184, 2008.
  13. Boza C et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up. Surgery for Obesity and Related Diseases, v. 6, n. 5, p. 470-475, 2010.
  14. Buchwald H et al. Bariatric surgery: a systematic review and meta analysis. Jama, v. 292, n. 14, p. 1724-1737, 2004.
  15. Golzarand M, Toolabi K, Farid R. The bariatric surgery and weight losing: a meta-analysis in the long-and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surgical Endoscopy, v. 31, n. 11, p. 4331-4345, 2017.
  16. Peterli, Ralph et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM BOSS randomized clinical trial. Jama, v. 319, n. 3, p. 255-265, 2018.
  17. Sheng B et al. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obesity Surgery, v. 27, n. 10, p. 2724-2732, 2017.
  18. Prevedello C F et al. Análise do impacto da cirurgia bariátrica em uma população do centro do estado do Rio Grande do Sul utilizando o método BAROS. Arquivos de Gastroenterologia, v. 46, n. 3, p. 199-203, 2009.
  19. Angrisani L et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obesity Surgery, v. 27, n. 9, p. 2279-2289, 2017.
  20. Le Roux, C W et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Annals of Surgery, v. 243, n. 1, p. 108, 2006.
  21. Le Roux, C W, Bueter M. The physiology of altered eating behaviour after Roux‐en‐Y gastric bypass. Experimental Physiology, v. 99, n. 9, p. 1128-1132, 2014.
  22. Miras AD, Le Roux C W. Mechanisms underlying weight loss after bariatric surgery. Nature reviews Gastroenterology & Hepatology, v. 10, n. 10, p. 575-584, 2013.
  23. Pareek M et al. Metabolic surgery: weight loss, diabetes, and beyond. Journal of the American College of Cardiology, v. 71, n. 6, p. 670-687, 2018.
  24. Hanipah ZN, Schauer PR. Surgical treatment of obesity and diabetes. Gastrointestinal Endoscopy Clinics, v. 27, n. 2, p. 191-211, 2017.
  25. Borg CM et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Journal of British Surgery, v. 93, n. 2, p. 210-215, 2006.
  26. Flancbaum L et al. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity. Surgery, v. 122, n. 5, p. 943- 949, 1997.
  27. Barros LM et al. Assessment of bariatric surgery results. Revista Gaúcha de Enfermagem, v. 36, n. 1, p. 21-27, 2015.
  28. Ribaric G, Buchwald JN, Mcglennon T W. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obesity Surgery, v. 24, n. 3, p. 437-455, 2014.
  29. Wang, Guo-Feng et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obesity Surgery, v. 25, n. 2, p. 199-208, 2015.

Most read articles by the same author(s)

1 2 > >>